Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
Immune-checkpoint blocking antibodies have demonstrated objective antitumor responses in multiple tumor types including melanoma, non-small cell lung cancer (NSCLC), and renal cell cancer (RCC). In melanoma, an increase in overall survival has been demonstrated with anti-CTLA-4 and PD-1 inhibition....
| Main Authors: | , , , , , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
BMJ Publishing Group
2016-06-01
|
| 叢編: | Journal for ImmunoTherapy of Cancer |
| 在線閱讀: | https://jitc.bmj.com/content/4/1/50.full |